Perry G. Nystrom

Intensive Care Medicine
4100 W 3rd St
Dayton, OH 45428

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

A Case Study and Literature Review of Local Anesthetic Systemic Toxicity During Placement of a Dual-chamber Pacemaker.

A Case Study and Literature Review of Local Anesthetic Systemic Toxicity During Placement of a Dual-chamber Pacemaker.

Journal: The Journal of innovations in cardiac rhythm management
Published: April 16, 2023

Chronic eosinophilic pneumonia: Adjunctive therapy with inhaled steroids.

Chronic eosinophilic pneumonia: Adjunctive therapy with inhaled steroids.

Journal: Respiratory medicine case reports
Published: May 04, 2017

Recurrent hydropneumothorax: An unusual presentation for malignant pleural mesothelioma.

Recurrent hydropneumothorax: An unusual presentation for malignant pleural mesothelioma.

Journal: Respiratory medicine case reports
Published: June 11, 2016

Platelet factor XIIIa release during platelet aggregation and plasma clot strength measured by thrombelastography in patients with coronary artery disease treated with clopidogrel.

Platelet factor XIIIa release during platelet aggregation and plasma clot strength measured by thrombelastography in patients with coronary artery disease treated with clopidogrel.

Journal: Platelets
Published: May 17, 2014

Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.

Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.

Journal: Journal of thrombosis and thrombolysis
Published: February 11, 2014

Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel response.

Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel response.

Journal: Clinical pharmacology : advances and applications
Published: December 20, 2013

Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response.

Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response.

Journal: Clinical pharmacology : advances and applications
Published: March 20, 2012

Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin.

Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin.

Journal: Platelets
Published: March 06, 2012
Showing 1-8 of 8

Last Updated: 09/26/2026